Revance Therapeutics Inc (RVNC)
3.025
-0.14
(-4.27%)
USD |
NASDAQ |
May 17, 16:00
3.02
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Shares Outstanding: 104.45M for April 30, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
April 30, 2024 | 104.45M |
March 31, 2024 | 104.41M |
March 08, 2024 | 104.22M |
March 06, 2024 | 104.21M |
February 16, 2024 | 88.21M |
December 31, 2023 | 87.96M |
October 31, 2023 | 87.81M |
September 30, 2023 | 87.81M |
July 31, 2023 | 87.96M |
June 30, 2023 | 87.95M |
April 28, 2023 | 84.04M |
March 31, 2023 | 84.02M |
March 10, 2023 | 83.85M |
February 16, 2023 | 82.80M |
December 31, 2022 | 82.39M |
October 31, 2022 | 82.27M |
September 30, 2022 | 82.29M |
September 15, 2022 | 82.31M |
July 29, 2022 | 73.11M |
June 30, 2022 | 73.12M |
April 29, 2022 | 72.77M |
March 31, 2022 | 71.76M |
March 11, 2022 | 71.43M |
February 17, 2022 | 71.45M |
December 31, 2021 | 71.58M |
Date | Value |
---|---|
October 28, 2021 | 71.79M |
September 30, 2021 | 71.84M |
July 28, 2021 | 71.83M |
June 30, 2021 | 71.80M |
April 27, 2021 | 71.53M |
March 31, 2021 | 71.41M |
March 11, 2021 | 71.38M |
February 28, 2021 | 71.41M |
February 22, 2021 | 69.85M |
February 12, 2021 | 71.38M |
December 31, 2020 | 69.18M |
October 30, 2020 | 66.55M |
September 30, 2020 | 66.59M |
July 24, 2020 | 65.93M |
July 23, 2020 | 65.78M |
June 30, 2020 | 57.31M |
June 18, 2020 | 57.21M |
June 01, 2020 | 57.18M |
May 31, 2020 | 57.15M |
May 15, 2020 | 57.12M |
April 24, 2020 | 57.05M |
March 31, 2020 | 57.03M |
March 16, 2020 | 57.03M |
February 13, 2020 | 56.93M |
January 24, 2020 | 56.88M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
44.10M
Minimum
Jul 26 2019
104.45M
Maximum
Apr 30 2024
71.39M
Average
71.45M
Median
Feb 17 2022
Shares Outstanding Benchmarks
AbbVie Inc | 1.766B |
Eli Lilly and Co | 950.41M |
Aquestive Therapeutics Inc | 91.04M |
Humacyte Inc | 119.08M |
AN2 Therapeutics Inc | 29.83M |